Greenlight’s David Einhorn pitches ‘boring essential-chemicals business’ Solvay
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 03 2024
0mins
Source: MarketWatch
- David Einhorn在Sohn投资大会上推荐价值股票：David Einhorn在曼哈顿举行的Sohn投资大会上再次推荐了一只价值股票。
- Greenlight Capital买入Solvay SA BE:SOLB股份：David Einhorn的对冲基金Greenlight Capital购入了比利时总部的拥有160年历史的“无聊的基础化学品业务”Solvay SA BE:SOLB的股份。
- Solvay是一家基础化学品企业：Solvay是一家总部位于比利时的基础化学品企业。
- Solvay公司简介：Solvay公司成立已有160年，主营业务为生产基础化学品。
- 新闻提到的投资者：新闻中提到的投资者是David Einhorn，他是Greenlight Capital的创始人。
Analyst Views on KVUE
Wall Street analysts forecast KVUE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KVUE is 18.86 USD with a low forecast of 17.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
1 Buy
7 Hold
0 Sell
Hold
Current: 17.750
Low
17.00
Averages
18.86
High
23.00
Current: 17.750
Low
17.00
Averages
18.86
High
23.00
About KVUE
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
